CYTOS BIOTECHNOLOGY AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07K PEPTIDES 3133
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8344111 Human monoclonal nicotine specific antibodiesSep 11, 08Jan 01, 13[A61K, C07K]
8119790 Antisense oligonucleotides for treating allergy and neoplastic cell proliferationOct 27, 05Feb 21, 12[A61K]
7138252 Molecular antigen arraysJul 14, 03Nov 21, 06[C12N]
7115266 Angiotensin peptide-carrier conjugates and uses thereofOct 04, 02Oct 03, 06[A61K]
6197502 Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined propertyNov 17, 97Mar 06, 01[C07H, C12Q, C12P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0202,281 Molecular Antigen ArrayAbandonedMay 30, 13Jul 23, 15[A61K, C12N]
2014/0200,338 OLIGONUCLEOTIDES CONTAINING HIGH CONCENTRATIONS OF GUANINE MONOMERSAbandonedOct 15, 13Jul 17, 14[C07H]
2014/0141,036 In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like ParticlesAbandonedDec 20, 12May 22, 14[C07K]
2014/0081,008 Scalable Process for Protein PurificationAbandonedApr 02, 13Mar 20, 14[C07K]
2013/0344,098 CAT Allergen Conjugates and Uses ThereofAbandonedDec 21, 12Dec 26, 13[A61K, C07K]
2013/0315,949 Molecular Antigen ArrayAbandonedDec 07, 12Nov 28, 13[A61K]
8574564 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivityExpiredOct 08, 09Nov 05, 13[A61K, A01N]
2013/0230,484 Interleukin-1 Conjugates and Uses ThereofAbandonedAug 01, 12Sep 05, 13[C07K]
2013/0142,821 Hapten-Carrier Conjugates and Uses ThereofAbandonedMay 21, 12Jun 06, 13[C07K]
8449874 Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseasesExpiredMar 29, 07May 28, 13[A61K]
2013/0115,189 Use of Interleukin-1 Beta Mutein Conjugates in the Treatment of DiabetesAbandonedSep 09, 10May 09, 13[A61K]
2012/0322,103 Scalable Fermentation ProcessAbandonedDec 22, 11Dec 20, 12[C12P]
2012/0263,743 INFLUENZA HEMAGGLUTININ COMPOSITIONS AND USES THEREOFAbandonedApr 30, 10Oct 18, 12[A61K, A61P, C07K]
2012/0214,976 Scalable Process for Protein PurificationAbandonedAug 22, 11Aug 23, 12[C07K]
8187607 Hapten-carrier conjugates and uses thereofExpiredOct 08, 08May 29, 12[A61K, C07D]
2012/0114,674 Molecular Antigen ArrayAbandonedApr 28, 11May 10, 12[A61K, A61P]
2011/0318,300 User of Interleukin-1 Conjugates in the Treatment of DiabetesAbandonedMar 05, 09Dec 29, 11[A61K, A61P]
2011/0305,723 Molecular Antigen ArrayAbandonedDec 23, 10Dec 15, 11[A61K, C12N, A61P, C07K]
2011/0306,113 Scalable Process for Protein PurificationAbandonedDec 23, 10Dec 15, 11[C12N]
2011/0293,649 In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like ParticlesAbandonedMar 19, 10Dec 01, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.